Thomas Lanni

Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer

Chirag Shah, Thomas Lanni, Mihai Ghilezan et al. · Brachytherapy · 2012 · 105 citations

Urology, Surgical Oncology, Low/intermediate Prostate Cancer +9

Stereotactic Radiotherapy Reduces Treatment Cost While Improving Overall Survival and Local Control Over Standard Fractionated Radiation Therapy for Medically Inoperable Non-Small-Cell Lung Cancer

Thomas Lanni, Inga S. Grills, Larry L. Kestin et al. · American Journal of Clinical Oncology · 2010 · 103 citations

Impact of a Prostate Multidisciplinary Clinic Program on Patient Treatment Decisions and on Adherence to NCCN Guidelines

Howard Korman, Thomas Lanni, Chirag Shah et al. · American Journal of Clinical Oncology · 2012 · 70 citations

Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapy

Siddhartha Yadav, Ovidiu Marina, A Parzuchowski et al. · Head & Neck · 2013 · 62 citations

Evaluating Radiotherapy Options in Breast Cancer: Does Intraoperative Radiotherapy Represent the Most Cost-Efficacious Option?

Chirag Shah, Shahed N. Badiyan, Shariq S. Khwaja et al. · Clinical Breast Cancer · 2013 · 59 citations

Adaptive Radiotherapy, Most Cost-efficacious Option, Surgical Oncology +9